Viewing Study NCT03444103


Ignite Creation Date: 2025-12-24 @ 7:10 PM
Ignite Modification Date: 2026-01-05 @ 1:08 AM
Study NCT ID: NCT03444103
Status: COMPLETED
Last Update Posted: 2020-09-09
First Post: 2018-01-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Pilot Trial of Clazakizumab in Late ABMR
Sponsor: Medical University of Vienna
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: EK1428/2017
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None OTHER View
None OTHER View